A class of metallohydrolases expands bile salt hydrolase activity in the gut

This study overturns the prevailing paradigm that bile salt hydrolase (BSH) activity is exclusively mediated by Ntn cysteine hydrolases by discovering and characterizing a novel, broadly distributed class of metal-dependent BSHs (mBSHs) in the gut microbiome that specifically target taurine-conjugated bile acids.

The Gist

Imagine your gut is a bustling, high-tech city. In this city, there are two main types of workers responsible for managing a special resource called bile acids. These bile acids are like "detergent blocks" produced by your liver to help digest fats. They arrive in the gut attached to little "handles" (amino acids like taurine or glycine) that make them soluble and safe to transport.

For decades, scientists believed there was only one type of worker in this city capable of unhooking these handles: a team of "Cysteine Hydrolases" (let's call them the C-Team). These workers were thought to be the only ones who could cut the handles off, a process essential for recycling bile acids and keeping the gut ecosystem healthy.

However, researchers noticed a mystery: Some gut bacteria were acting like they could cut these handles, yet they didn't have the blueprints (genes) for the C-Team. They were doing the job without the right tools.

The Big Discovery: The "Metal-Dependent" Team
This paper reveals that there is actually a second, previously hidden team of workers: the Metal-Dependent Bile Salt Hydrolases (mBSHs). Think of them as a specialized Swiss Army Knife crew that uses metal (like zinc) as a tool to do the job, rather than the chemical "scissors" used by the C-Team.

Here is the breakdown of what they found, using simple analogies:

1. The Specialized Tool (The "Taurine" Key)

The C-Team is like a general contractor; they can cut off many different types of handles. But the new mBSH team is incredibly picky. They are specialists who only cut off the taurine handles.

• Analogy: Imagine a parking garage where cars (bile acids) have different colored tags. The C-Team can remove red, blue, and green tags. The new mBSH team only removes the purple tags (taurine). If a car has a red tag, the mBSH team ignores it completely.

2. How They Were Found (The "Chemical Detective")

The scientists didn't just guess; they used a "chemical detective" approach. They created a special sticky probe (a chemical trap) that only latches onto proteins that bind bile acids. When they tested this on gut bacteria, it stuck to a protein from a bacterium called Turicibacter faecis.

• The Twist: When they looked at this protein, it didn't look like the C-Team at all. It looked like a metal-using enzyme (an amidohydrolase) that was previously thought to do something completely different. It was a case of "imposter syndrome" in the protein world!

3. Why the Metal Matters

The researchers proved these new enzymes need metal to work. When they removed the metal (using a chemical sponge called a chelator), the enzymes stopped working. But when they put the metal back in, the enzymes came back to life.

• Analogy: It's like a car that won't start without a battery. The metal is the battery. Without it, the engine (the enzyme) is silent.

4. The "Why" Behind the Specialization

Why would bacteria evolve a team that only cuts taurine handles?

• The Nutrient Hunt: Taurine contains nitrogen and sulfur. By cutting off the taurine handle, these bacteria get a free meal of nitrogen and sulfur to grow.
• The Energy Loop: Some of these bacteria use the sulfur from taurine to generate energy, similar to how some bacteria use oxygen. It's a survival strategy.
• The Partnership: Some bacteria have both teams (the general C-Team and the specialist mBSH team). This allows them to clear every type of handle, giving them a massive advantage over other bacteria in the gut.

5. The Connection to Heart Disease

The most exciting part of the paper is the link to human health. The researchers looked at the guts of people with cardiovascular disease (CVD) (heart disease).

• They found that the abundance of these new mBSH enzymes changed in people with heart disease.
• Specifically, the "good" mBSHs (from bacteria like Mediterranibacter gnavus) increased, while the "sulfur-reducing" mBSHs (from bacteria like Bilophila wadsworthia) decreased.
• The Takeaway: Since taurine is known to protect against heart disease, the way these bacteria process taurine might be a missing piece of the puzzle in understanding why some people get heart disease and others don't.

Summary

This paper overturns a long-held rule in biology: "Bile acid cutting is done only by the C-Team."
Instead, the gut is a complex city with two different crews doing the job. One is a generalist, and the other is a metal-powered specialist that only eats taurine. This discovery changes how we understand gut health, how bacteria fight for food, and potentially how we treat heart disease by managing the balance of these microscopic workers.

Technical Summary

1. Problem Statement

Bile acids are critical steroidal metabolites that regulate host physiology, lipid absorption, and gut microbiome ecology. Their structural diversification relies on Bile Salt Hydrolases (BSHs), enzymes that cleave the amide bond of liver-derived bile acid amidates (BAAs).

• Current Dogma: All known BSH activity has been attributed exclusively to the N-terminal nucleophile (Ntn) superfamily of cysteine hydrolases (cBSHs).
• The Gap: Several prominent gut anaerobic bacteria (e.g., Collinsella intestinalis, Bilophila wadsworthia, Clostridioides difficile) exhibit BSH activity but lack genes encoding canonical Ntn-family cBSHs. The molecular identity and mechanism of this "missing" BSH activity remained unknown, creating a blind spot in understanding bile acid metabolism and host-microbe co-metabolism.

2. Methodology

The authors employed a multidisciplinary approach combining chemoproteomics, enzymology, structural modeling, and bioinformatics:

• Chemoproteomic Discovery:

  • Used a cholic acid-based chemical probe (containing an electrophilic warhead and a click chemistry handle) to label bile acid-binding proteins in murine gut bacterial lysates.
  • Enriched labeled proteins via click chemistry and identified them using mass spectrometry.
  • Key Finding: The probe highly enriched a predicted metal-dependent hydrolase from Turicibacter faecis (Tf), annotated as an N-substituted formamide deformylase (Nsfd), which is not an Ntn hydrolase.

• Biochemical Characterization:

  • Cloned, overexpressed, and purified the Tf amidohydrolase and homologs from other gut bacteria (Beduini massiliensis, Hungatella effluvii, Clostridioides difficile, etc.).
  • Activity Assays: Verified hydrolysis of taurocholic acid (TCA) into cholic acid and taurine using LC-MS and a ninhydrin assay.
  • Metal Dependence: Confirmed the enzyme's reliance on divalent metal cofactors by treating with the chelator 1,10-phenanthroline (inactivating the enzyme) and rescuing activity by reconstituting with first-row transition metals (e.g., Zn²⁺, Co²⁺).
  • Substrate Specificity: Tested a panel of bile acid conjugates (glycine, taurine, $\beta$-alanine) to determine selectivity.

• Structural and Mutagenesis Studies:

  • Generated structural models of the enzyme complexed with taurodeoxycholic acid (TDCA) and Zn²⁺ using Boltz-2.
  • Identified conserved residues (Ser144, Gln290, Asn337, His393) predicted to coordinate the taurine sulfonate group.
  • Performed site-directed mutagenesis (S144A, Q290A, N337A) to validate the role of these residues in substrate recognition.

• Genomic and Metagenomic Analysis:

  • Constructed Sequence Similarity Networks (SSNs) to map the distribution of these enzymes across the human gut microbiome (Unified Human Gut Protein catalog).
  • Analyzed co-occurrence of these new enzymes with taurine catabolism genes (Tpa, SarD, IslA, Xsc) and dissimilatory sulfite reductases.
  • Quantified gene abundances in fecal metagenomes from patients with atherosclerotic cardiovascular disease (CVD) versus healthy controls.

3. Key Contributions

The paper introduces and characterizes a previously unknown class of enzymes: Metal-Dependent Bile Salt Hydrolases (mBSHs).

• Novel Enzyme Class: mBSHs belong to the amidohydrolase superfamily (specifically the Nsfd subfamily) and are distinct from the canonical Ntn cysteine hydrolases.
• Strict Substrate Selectivity: Unlike cBSHs, which can deconjugate both glycine- and taurine-conjugated bile acids, mBSHs are exclusively selective for taurine-conjugated BAAs.
• Mechanistic Insight: The selectivity is driven by a specific active site architecture where conserved residues (Ser, Gln, Asn) form hydrogen bonds with the sulfonate group of taurine, a feature absent in glycine-conjugated substrates.
• Metabolic Link: The study establishes a direct link between mBSH activity and microbial taurine utilization pathways, suggesting these enzymes allow bacteria to scavenge nitrogen and carbon from taurine while facilitating dissimilatory sulfite metabolism.

4. Key Results

• Discovery & Validation: The Tf amidohydrolase was confirmed to hydrolyze TCA efficiently. Activity was abolished by chelation and restored by Zn²⁺, confirming its metalloenzyme nature.
• Selectivity: A panel of 212 homologs from diverse phyla (Actinobacteria, Bacillota, Spirochaetota, Thermodesulfobacteriota) showed exclusive activity toward taurine-conjugates. They showed no activity against $\beta$-alanocholic acid or N-acetyltaurine, confirming the sulfonate group is the critical recognition motif.
• Structural Determinants: Mutagenesis of the sulfonate-binding residues (S144, Q290, N337) significantly reduced or abolished TDCA hydrolysis, confirming the structural basis for taurine specificity.
• Genomic Distribution: mBSHs are widespread in the human gut. Approximately 50% of genomes containing mBSHs lack canonical cBSHs. Many genomes possess both mBSH and cBSH, suggesting a complementary strategy to broaden the substrate scope for deconjugation.
• Metabolic Integration: Genomes with mBSHs frequently harbor taurine catabolism genes (Tpa, SarD) and sulfite reduction pathways (IslA, Xsc, Dsr), indicating mBSHs facilitate energy harvest via sulfur and nitrogen acquisition.
• Clinical Association: Analysis of CVD metagenomes revealed distinct shifts in mBSH abundance:
  • Increased: Multi-phylum mBSH cluster (e.g., Mediterranibacter gnavus, Enterocloster bolteae).
  • Decreased: Thermodesulfobacteriota cluster (e.g., Bilophila wadsworthia).
  • This correlates with known disease-associated shifts in M. gnavus (pro-inflammatory) and Bilophila (often associated with high-fat diets but reduced in this specific CVD cohort context).

5. Significance

• Paradigm Shift: The discovery overturns the long-held belief that BSH activity is exclusively provided by Ntn cysteine hydrolases, revealing a second, metal-dependent mechanism.
• Expanded Metabolic Landscape: It significantly broadens the known scope of bile acid biotransformations, explaining "orphan" BSH activities in key gut pathogens and commensals.
• Host-Microbe Crosstalk: The findings highlight a previously unrecognized connection between bile acid metabolism and microbial taurine utilization. This suggests that mBSHs are not just gatekeepers for secondary bile acid formation but are central to bacterial nitrogen/sulfur metabolism.
• Disease Relevance: The differential abundance of mBSHs in cardiovascular disease suggests these enzymes (and the bacteria harboring them) may play a role in the pathophysiology of CVD, potentially through the modulation of taurine levels and the production of specific secondary bile acids or sulfide metabolites.
• Therapeutic Potential: Understanding the distinct active sites of mBSHs vs. cBSHs opens avenues for developing specific inhibitors or probiotics to modulate bile acid pools and taurine metabolism for treating metabolic and inflammatory diseases.